Amygdala and regional volumes in treatment-resistant versus nontreatment-resistant depression patients.
Anca-Larisa SanduEric ArtigesAndré GalinowskiThierry GallardaFrank BellivierHervé LemaitreBernard GrangerDamien RinguenetEleni T TzavaraJean-Luc MartinotMarie-Laure Paillère MartinotPublished in: Depression and anxiety (2017)
Higher GM volume in amygdala detected in TRD patients might be seen in perspective with vulnerability to chronicity, revealed by medication resistance.